Clinical signatures of SYNGAP1-related disorders through data integration
Authors:
- Jillian L. McKeeJMJillian L. McKee
- 19 March 2025
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 27 (6) , 101419
Abstract
No abstract availableKeywords
Funding Information
- American Epilepsy Society
- National Institute of Neurological Disorders and Stroke (R01 NS131512-01)
- National Institute of Neurological Disorders and Stroke (K02 NS112600)
- National Institute of Neurological Disorders and Stroke (R01 NS127830-01A1)
- American Academy of Neurology
- American Brain Foundation
- Epilepsy Foundation
- Pediatric Epilepsy Research Foundation
This publication has 35 references indexed in Scilit:
- Upregulation of SYNGAP1 expression in mice and human neurons by redirecting alternative splicingNeuron, 2023
- Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discoveryHuman Mutation, 2022
- Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial DesignClinical Pharmacology & Therapeutics, 2021
- Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic EncephalopathiesNeurotherapeutics, 2021
- Establishing a learning healthcare system to improve health outcomes for people with epilepsyEpilepsy & Behavior, 2021
- CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model miceNeurobiology of Disease, 2020
- SYNGAP1 mutations: Clinical, genetic, and pathophysiological featuresInternational Journal of Developmental Neuroscience, 2019
- Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disordersMolecular and Cellular Neuroscience, 2018
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- The Human Phenotype Ontology: A Tool for Annotating and Analyzing Human Hereditary DiseaseThe American Journal of Human Genetics, 2008